News
BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the drug discovery research for lecanemab (product name Leqembi®), an antibody indicated for early Alzheimer's ...
The Global Neurodegeneration Proteomics Consortium (GNPC) has published a series of research papers detailing their efforts ...
Illimis Therapeutics’ Series B round was led by Korean venture capital firm DSC Investment. Seoul-based Illimis Therapeutics ...
AI chatbots are becoming stand-ins for pets and partners — offering comfort, connection and raising new concerns.
Japanese drugmaker JCR Pharmaceuticals has entered into a joint collaboration, option and license agreement with US biotech Acumen Pharmaceuticals to develop a novel therapeutic candidate for the ...
9hon MSN
All forms of walking can provide mental health benefits. When you walk, your body releases mood-boosting hormones including endorphins, oxytocin, and dopamine, says Shulman. So beyond the long-term ...
Optimists’ brains show strikingly similar patterns when imagining the future, while pessimists’ brains display more ...
3d
YouTube on MSNOlympic Champion retiresNina Derwael has retired from gymnastics. Keywords: D-Score, fails, falls, sticks, spotters, sporteverywhere, saves, gymnastics, Simone Biles, Rebeca Andrade, Sunisa Lee, MyKayla Skinner, Jordan ...
The study confirms that adopting a healthy lifestyle is important to achieve optimal health as well as managing the ...
Acumen and JCR aim to develop a product leveraging Acumen's amyloid beta oligomer-selective antibody expertise and JCR's transferrin-receptor-targeting blood-brain barrier-penetrating technologyPrecli ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results